Erosive mucosal lichen planus: Response to topical treatment with tacrolimus

British Journal of Dermatology

Volumn 140, Issue 2, 1999, Pages 338-342

  Vente, C ^a   Reich, K ^a   Rupprecht, R ^a   Neumann, C ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

Mucosal lichen planus; Tacrolimus

Indexed keywords

TACROLIMUS;

ADULT; ARTICLE; CLINICAL ARTICLE; DISEASE SEVERITY; FLUORESCENCE POLARIZATION IMMUNOASSAY; HEALING; HUMAN; LICHEN PLANUS; PATIENT COMPLIANCE; PRIORITY JOURNAL; RELAPSE; RISK FACTOR; SKIN INFLAMMATION; TOPICAL TREATMENT; WOUND HEALING;

ADMINISTRATION, TOPICAL; AGED; CHRONIC DISEASE; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LICHEN PLANUS; MALE; MIDDLE AGED; TACROLIMUS;

EID: 0032989851     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.1999.02672.x     Document Type: Article

References (20)

1. Meingassner JG, Stütz A. Immunosuppressive macrolides of the type FK 506: a novel class of topical agents for treatment of skin diseases? J Invest Dermatol 1992; 98: 851-5.
2. The European FK 506 Multicentre Psoriasis Study Group. Systemic tacrolimus (FK 506) is effective for the treatment of psoriasis in a double-blind, placebo controlled study. Arch Dermatol 1996; 132: 419-23.
3. Jegasothy BV, Ackerman CD, Todo ST et al. Tacrolimus (FK 506) - a new therapeutic agent for severe recalcitrant psoriasis. Arch Dermatol 1992; 128: 781-5.
4. Abu-Elmagd K, Jegasothy BV, Ackermann CD et al. Efficacy of FK 506 in the treatment of recalcitrant pyoderma gangrenosum. Transplant Proc 1991; 123: 3328-9.
5. Aoyama H, Tabata N, Tanaka M et al. Successful treatment of resistant facial lesions of atopic dermatitis with 0.1% FK 506 ointment. Br J Dermatol 1995; 133: 492-500.
6. Lauerma AI, Maibach HI. Topical FK 506 - clinical potential or laboratory curiosity? Dermatology 1994; 188: 173-6.
7. Ruzicka T, Bieber T, Schöpf E et al. The European Tacrolimus Multicenter Atopic Dermatitis Study Group. A short-term trial of tacrolimus ointment for atopic dermatitis, N Engl J Med 1997; 337: 816-21.
8. Lewis FM, Vulval lichen planus. Br J Dermatol 1998; 138: 569-75.
9. Boyd AS, Neldner KH. Lichen planus. J Am Acad Dermatol 1991; 25: 593-619.
10. Thorn JJ, Holmstrup P, Rindum J, Pinborg JJ. Course of various clinical forms of oral lichen planus: a prospective follow up of 611 patients. J Oral Pathol Med 1988; 17: 213-18.
11. Shiohara T, Moriya N, Toraka Y. Immunopathological study of lichenoid skin diseases: correlation between HLA-DR positive keratinocytes of Langerhans-cells and epidermotropic T cells. J Am Acad Dermatol 1988; 18: 67-74.
12. Yamamoto T, Osaki T. Characteristic cytokines generated by keratinocytes and mononuclear infiltrates in oral lichen planus. J Invest Dermatol 1995; 104: 784-8.
13. Cottini F, Solinas A, Piga MR et al. Lichen planus, chronic liver diseases and immunologic involvement. Arch Dermatol Res 1988; 280: 55-60.
14. Bennion SD, Middleton MH, David-Bajar KM et al. In three types of interface dermatitis, different patterns of expression of intercellular adhesion molecule-1 (ICAM-1) indicate different triggers of disease. J Invest Dermatol 1995; 105 (Suppl.): 71-9.
15. Gruppo Italiano Studi Epidemiologici in Dermatologia (GISED). Lichen planus and liver disease: a multicenter case-control study Br Med J 1990; 300: 227-30.
16. Sanchez-Perez J, de Castro M, Buezo GF et al. Lichen planus and hepatitis C virus: prevalence and clinical presentation of patients with lichen planus and hepatitis C virus infection. Br J Dermatol 1996; 134: 715-19.
17. Nagao Y, Sata M, Ide T et al. Development and exacerbation of oral lichen planus during and after interferon therapy for hepatitis C. Eur J Clin Invest 1996; 26: 1171-4.
18. Jauregui L, Garcia Patos V, Pedragosa R et al. Lichen planus associated with liver disease caused by hepatitis C virus. Gastroenterol Hepatol 1996; 19: 507-10.
19. Eisen D, Ellis CN, Duel EA et al. Cyclosporin wash for oral lichen planus. Lancet 1990; 335: 535-6.
20. Sieg P, Von Domarus H, Von Zitzewitz V et al. Topical cyclosporin in oral lichen planus: a controlled, randomized prospective trial. Br J Dermatol 1995; 132: 790-4.